Distillate Capital Partners’s HCA Healthcare HCA Stock Holding History

Distillate Capital Partners’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-54,117	Closed	-$23.1M	–	124
2025 Q3	$23.1M	Sell	54,117 -716	-1%	-$278K	1.2%	22
2025 Q2	$21M	Sell	54,833 -19,744	-26%	-$7.11M	1.13%	28
2025 Q1	$25.8M	Sell	74,577 -5,917	-7%	-$1.9M	1.32%	13
2024 Q4	$24.2M	Buy	+80,494	New	+$28.1M	1.19%	20
2022 Q4	–	Sell	-45,695	Closed	-$8.68M	–	136
2022 Q3	$8.68M	Buy	45,695 +10,884	+31%	+$2.17M	1.16%	16
2022 Q2	$5.85M	Buy	34,811 +3,638	+12%	+$782K	0.84%	50
2022 Q1	$7.81M	Buy	31,173 +7,147	+30%	+$1.79M	1.11%	25
2021 Q4	$6.17M	Buy	24,026 +4,516	+23%	+$1.11M	1.04%	27
2021 Q3	$4.74M	Buy	19,510 +1,938	+11%	+$474K	1.26%	16
2021 Q2	$3.63M	Buy	17,572 +258	+1%	+$52.6K	1.01%	29
2021 Q1	$3.26M	Buy	17,314 +1,860	+12%	+$328K	1.06%	26
2020 Q4	$2.51M	Buy	+15,454	New	+$2.26M	1.2%	17

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Distillate Capital Partners's HCA Position: Q4 2025 in Review

Distillate Capital Partners sold out of HCA Healthcare (HCA) in Q4 2025, closing a stake of 54,117 shares — an estimated $23.1M sold.

Distillate Capital Partners first reported a position in HCA in Q4 2020 and held it in 12 quarters. The position peaked at $25.8M in Q1 2025. 1,395 funds tracked by Wall St. Rank hold HCA as of Q4 2025.

Distillate Capital Partners reported no remaining HCA Healthcare position as of Q4 2025 after selling out during the quarter.
Distillate Capital Partners sold 54,117 HCA Healthcare shares in Q4 2025, an estimated $23.1M.
Distillate Capital Partners first reported a position in HCA Healthcare in Q4 2020 and held it in 12 quarters.
Distillate Capital Partners's HCA Healthcare position peaked at $25.8M in Q1 2025.
1,395 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2025.

Based on Distillate Capital Partners's 13F filing for Q4 2025, filed 12 Feb 2026.